Hongli Du

3.1k citations
92 papers · 1.6k indexed · h-index 23
Topics
Immune Cell Function and Interaction (9 papers)Cancer-related molecular mechanisms research (9 papers)RNA modifications and cancer (8 papers)

In The Last Decade

Hongli Du

89 papers receiving 1.5k citations

Peers

Hongli Du
Comparison fields: 5 of 120
  • Molecular Biology 807
  • Cancer Research 322
  • Immunology 223
  • Public Health, Environmental and Occupational Health 186
  • Genetics 162
Replace Nataša Kopitar‐Jerala with:
Nataša Kopitar‐Jerala Slovenia
Frederick W. Holtsberg United States
Yinghui Li China
Lin Zhu China
Chih‐Peng Chang Taiwan
Satish Devadas India
Hong Yu China
Jianping Zhang China
Ida Biunno Italy
Carmen Punzón Spain
Hongli Du relative to Nataša Kopitar‐Jerala Slovenia Nataša Kopitar‐Jerala's profile →
Citations per field
00.5×1.5×1.9×
Nataša Kopitar‐Jerala · 1×
Citations per year

Countries citing papers authored by Hongli Du

Since Specialization
Citations

This map shows the geographic impact of Hongli Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongli Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongli Du more than expected).

Fields of papers citing papers by Hongli Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hongli Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongli Du. The network helps show where Hongli Du may publish in the future.

Co-authorship network of co-authors of Hongli Du

This figure shows the co-authorship network connecting the top 25 collaborators of Hongli Du. A scholar is included among the top collaborators of Hongli Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hongli Du. Hongli Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 2
3 12
4 3
5 5
6 26
7 34
8 9
9 21
10 4
11 29
12 27
13 6
14 33
15 47
16 50
17
Molecular Modeling Studies on NADP-Dependence of Candida Tropicalis Strain Xylose Reductase
7
18 7
19 121
20 49

About Hongli Du

Hongli Du is a scholar working on Biological Psychiatry, Cancer Research and Virology, having authored 92 papers that have together received 1.6k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Cancer-related molecular mechanisms research (9 papers) and RNA modifications and cancer (8 papers). The work is most often cited by research in Cancer Research (322 citations), Biological Psychiatry (52 citations) and Molecular Biology (807 citations). Hongli Du has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Jinfen Wei, Meiling Hu, Shudai Lin, Zixi Chen, Yuhuan Meng, Yunmeng Bai, Jiayun Chen, Lizhen Huang, Ying Lin and Min Zhuo. Their work appears in journals such as Nature Communications, Bioinformatics and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026